Header
Commercialisation of intellectual property
   

Ventures Process

Principal holdings
    Novocellus
    Geomerics
    NeuroTargets
    Parsortix

Other holdings
    Acolyte Biomedica
    Synature

Exits
    Provexis
    Exago

Ventures Process

ANGLE is an expert in commercialising of intellectual property (IP) developed by universities, research organisations and corporates and developing high growth technology-based companies.

By combining experienced start-up managers with capital, ANGLE’s in-house Progeny® process satisfies the unique requirements of early-stage technology businesses. ANGLE creates, develops and operates new companies that are able to bridge the ‘credibility gap’ between sources of IP and the conventional investment community.

Partnerships:
ANGLE has established relationships with a wide range of universities, government research establishments and major corporates.  These organisations generate world class intellectual property. ANGLE has founded spin-out companies with the UK universities of Bristol, Cambridge and York and the US universities of New York, Southern California and Virginia as well as other major research organisations including Dstl Porton Down, Rowett Institute and British Telecom.

Progeny®: A unique approach
The Progeny® process draws on a diverse set of business methodologies in building a unique approach to early-stage investment. It provides ANGLE’s technology partners with the right package of skills, resources and experience to overcome the usual barriers to IP exploitation. Progeny® is focused on creating businesses that are designed to be sold to trade buyers. By deploying a project approach, Progeny® manages the risk and uncertainty of creating something new.

Progress Chart